Question | Answer |
---|---|
Clinic | Â |
What are the diagnostic criteria for AD? | There are 12 diagnostic inclusion criteria and 9 exclusion criteria. |
Does Medicare D cover Donepezil? | Medicare D covers 2 brand name formulations of Donepezil: Aricept and Aricept ODT. |
Have any AD patients been treated for other neurological conditions? | Patient 2 was found to suffer from AD and depression. |
Clinical Trial | Â |
Since my patient is suffering from drug-induced side effects for AD treatment, can an AD clinical trial with a different mechanism of action (MOA) be identified? | Of the 438 drugs linked to AD trials, only 58 are in active trials and only 2 (Doxorubicin and IL-2) have a documented MOA. 78 AD-associated drugs have an established MOA. |
Find AD patients without the APOE4 allele as these would be good candidates for the clinical trial involving Bapineuzumab? | Of the four patients with AD, only one does not carry the APOE4 allele, and may be a good candidate for the clinical trial. |
What active trials are ongoing that would be a good fit for Patient 2? | 58 Alzheimer trials: 2 mild cognitive impairment, 1 hypercholesterolaemia, 66 my-ocardial infarction, 46 anxiety, and 126 depression. |
Research | Â |
What genes are associated with or implicated in AD? | Diseasome and PharmGKB indicate at least 97 genes have some association with AD. |
Which SNPs may be potential AD biomark-ers? | PharmGKB reveals 63 SNPs |
Which market drugs might potentially be re-purposed for AD because they modulate AD implicated genes? | 57 compounds or classes of compounds that are used to treat 45 diseases, including AD, hyper/hypotension, diabetes and obesity. |